Servier BioInnovation launches in the USA with two hires

French independent pharma company Servier today announced the appointments of Christian Schubert and Rekha Paleyanda as directors of Servier BioInnovation along with the opening of the Servier BioInnovation office in Cambridge, Massachusetts.

The appointments of Dr Schubert and Dr Paleyanda, who will head Servier’s US R&D and external innovation, and business development and licensing (BD&L) activities, respectively, will operationalize the launch of Servier BioInnovation in the USA. Located in the heart of one of the world’s leading biotechnology hubs in the Cambridge Innovation Center at Kendall Square, Servier BioInnovation will lead Servier’s expansion efforts into the U.S. innovation ecosystem.

“Servier BioInnovation represents Servier’s commitment to expanding its growing presence in the US for the long-term through R&D and business development and licensing activities,” said Christophe Thurieau, director of research centers and the Servier International Research Network (SIRN) at Servier’s R&D headquarters.